<DOC>
	<DOCNO>NCT00118547</DOCNO>
	<brief_summary>The purpose pilot trial provide preliminary evidence effectiveness brief behavioral intervention use telemedicine home monitoring help individual multiple sclerosis adhere medication slow disease progression .</brief_summary>
	<brief_title>Health Behavior Change Chronic Disease Management</brief_title>
	<detailed_description>There increase recognition coordinate approach disease management improve medication adherence . Intervention chronic illness may view multidisciplinary collaborative process base upon behavioral principle , include idea illness management skill learn behavior self-directed , motivation self-efficacy affect self care , monitor respond change physical mental health improves adaptation illness , health care system support hinder self care . Preliminary finding suggest telemedicine home monitoring provide cue medication administration , brief evaluation potential barrier ( e.g. , fatigue , cognition , side effect ) , identification area future education ( e.g. , additional injection training ) , opportunity feedback provider ( e.g. , side effect ) well tolerate may improve self monitoring chronic medical condition . The propose study six-month , two group parallel-design , control trial evaluate feasibility obtain effect size estimate behavioral intervention improve adherence MS disease modify therapy ( DMT ) use telemedicine home monitoring . Monitoring include brief weekly text-based prompt complete series approximately 10-15 question regard factor expect affect adherence DMT . Areas assessment include development side effect ( e.g. , flu-like symptom ) , disease specific symptom ( e.g. , fatigue ) , adherence expectation , DMT self-efficacy . MS clinic staff examine responses weekly home monitoring assessment . They provide telephone follow-up medical advice , support , specific educational material , referral service necessary . Potential service also inform Research Project 1 , follow general principle select standardized list ( e.g. , additional injection training , energy management strategy fatigue ) , tailor individual patient need base upon information obtain home monitoring . Primary outcome measure assess feasibility percentage eligible participant complete study protocol , comparison home monitoring recipient control regard overall benefit participation . Outcomes assessed via monthly telephone call .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Must Multiple Sclerosis disease modify therapy Inability participate selfcare</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Adherence</keyword>
	<keyword>Medication</keyword>
	<keyword>Multiple Sclerosis</keyword>
</DOC>